Global Voriconazole (CAS 137234-62-9) Market Outlook 2017-2021

Pharmaceutical

Voriconazole (CAS 137234-62-9) 2017 report studies in Global Market, especially in Europe, North America, South America, Asia (Excluding China), China and ROW, with definitions, classifications, applications and industry chain structure, development trends, competitive landscape analysis, and key regions development and import/export status to 2021.



Voriconazole (INN, brand name Vfend vee-fend, manufactured by Pfizer) is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. These are generally seen in patients who are immunocompromised, and include invasive candidiasis, invasive aspergillosis, and certain emerging fungal infections.

This report provides detailed analysis of worldwide markets for Voriconazole (CAS 137234-62-9) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Voriconazole (CAS 137234-62-9) market and further lays out an analysis of the factors influencing the supply/demand for Voriconazole (CAS 137234-62-9), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC’s report, Global Voriconazole (CAS 137234-62-9) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Voriconazole (CAS 137234-62-9) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Voriconazole (CAS 137234-62-9) market are Pfizer (USA), Dishman Group (India), Medichem (Spain), Nivon (India), Neuland Laboratories (India), LEE PHARMA (India), Lummy (China), Rundu Pharma (China), Zhejiang Huahai (China), Medco Huakang (China), Aventis (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Voriconazole (CAS 137234-62-9) industry has been provided.

Table of Contents

“Part 1. Exclusive Summary

Part 2. Methodology
2.1 Research Methodology
2.2 Geographic Scope
2.3 Years Considered

Part 3. Introduction
3.1 Definition
3.2 Supply Chain Structure
3.2.1 Raw Material Supply
3.2.2 Traders & Distributors
3.2.3 Key Customers
3.3 Manufacture
3.3.1 Manufacturing Process
3.3.2 Production Cost

Part 4. Market Landscape
4.1 Global Voriconazole (CAS 137234-62-9) Market Size (Volume) 2011-2016
4.1.1 Overview
4.1.2 Global Voriconazole (CAS 137234-62-9) Production
4.1.3 Top 10 Voriconazole (CAS 137234-62-9) Companies (Volume Share)
4.2 Global Voriconazole (CAS 137234-62-9) Market Size (Value) 2011-2016
4.2.1 Overview
4.2.2 Global Voriconazole (CAS 137234-62-9) Production Value
4.2.3 Top 10 Voriconazole (CAS 137234-62-9) Companies (Revenue Share)

Part 5. Segmentation by Products
5.1 Type 1
5.2 Type 2
5.3 Type 3

Part 6. Segmentation by End-users
6.1 Customer Segment 1
6.2 Customer Segment 2
6.3 Customer Segment 3
6.4 Customer Segment 4

Part 7. Geographical Segmentation
7.1 North America Voriconazole (CAS 137234-62-9) Market
7.1.1 North America Market Overview
7.1.2 North America Price & Margin
7.1.3 North America Trade Balance
7.2 EMEA Voriconazole (CAS 137234-62-9) Market
7.2.1 EMEA Market Overview
7.2.2 EMEA Price & Margin
7.2.3 EMEA Trade Balance
7.3 Asia Pacific Voriconazole (CAS 137234-62-9) Market
7.3.1 Asia Pacific Market Overview
7.3.2 Asia Pacific Price & Margin
7.3.3 Asia Pacific Trade Balance

Part 8. Market Forecast
8.1 Market Size by Volume 2016-2021
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 RoW
8.2 Market Size by Value 2016-2021
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 RoW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 RoW
8.4 Consumption Forecast by End-users
8.5 Consumption Forecast by Products

Part 9. Company Profiles
9.1 Company A
9.1.1 Overview
9.1.2 Products Offered
9.1.3 Business Performance
9.2 Company B
9.3 Company C
9.4 Company D

Part 10. Market Dynamics
10.1 Market Drivers
10.2 Market Constraints
10.3 Market Strategies

Part 11. Competitive Landscape
11.1 Mergers & Acquisitions
11.2 New Product Launches
11.3 Expansions
11.4 Other Developments

Part 12. Appendix


Inquiry Before Buying



Request For Sample